Angie Coats
HCS/550
May 17, 2015
Anne Koepsell
Global Perspective on Health Policy
The macro perspective on health policy issue will be about stem cell. Stem cell problems will be identified and how these policy issues resulted in the creation of health care policy. Both the state and federal policy steps regarding stem cell development process will be discussed. The difference between the stem cell policy development and implementation, along with how the stakeholders became involved in the process and why his or hers voice was heard regarding the change in stem cell policy will be talked about.
The topic of discussion is on stem cell, before the discussion can begin about problems issues and how …show more content…
The compromise would allow the “medical research underwriters, the National Institutes of Health (NIH) to begin funding on these studies using stem cells harvested from surplus embryos before August 9, 2001” (Vestal, 2015, p14.) Back in the 1970s, federal policymakers banned funding for test tube babies, which laid out the preliminary work for future discussions on whether the United States government should fund research. In 1973, Roe v. Wade, the U.S. Supreme Court handed down the decision to legalizing abortion which caused many opponents to halt stem cell research because of the destruction of human life. The early 1990s, President Clinton approved “funding for stem cell research involving surplus embryos from fertility clinics and placed a moratorium on support for research involving human cloning” (Vestal, 2015, p.18). In 1995, Congress overrode President Clinton’s decision to fund some types of stem cell research, this prevents NIH from funding any research that harms or destroys human …show more content…
Before the discussion can begin on the difference between policy development and implementation the need to look at how human embryos affect stem cell research will help lay the foundation and understanding why implementation may never be approved. Human embryonic stem cells (hES) are the inner most cell mass that has been cultured in a lab for three to five days. The removals of these hES cells benefit the reason on human embryos. The ethical issues of hES research covers part of the same area that goes with embryo research. To be more specific, the ethical question is hES research routes around the moral issue of the status of the embryo. As of March 2009, President Obama issued an executive order that removed some barriers to responsible scientific research involving human stem cells. This order allowed NIH funded programs to establish policy and procedures on the ethical area, scientific worthy, and managing research within the accordance of the law. The order is specific on which stem cells NIH can fund research for and include certain hES and other stem cells. The guidelines of the order are:
1. Responsible research with hESCs has the potential to improve our understanding of human health and illness and discover new ways to prevent and/or treat